Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/10/2003US20030129746 Monoclonal antibodies for Hepatitis C virus (HCV) infection
07/10/2003US20030129744 Bvdv virus-like particles
07/10/2003US20030129733 Inactivated genomes of diploid microorganisms which are inducible into haploid forms; drug screening
07/10/2003US20030129729 Genetic engineered Dna; attenuation, deactivation viruses
07/10/2003US20030129727 Nucleic acid encoding 5'-3' exonuclease of bacteriophage RM 378
07/10/2003US20030129722 Comprises phospholipid scramblase phosphorylated by protein kinases; antithrombotic agents
07/10/2003US20030129720 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129705 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
07/10/2003US20030129703 Modified dorsal tissue affecting factor and compositions
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129701 Detecting a mutation in the RAR epsilon receptor nucleic acid sequences and detecting a level of the soluble form of the receptors
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129696 Polynucleotides and polypeptides encoding receptors
07/10/2003US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129691 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129689 Nucleotide sequence that encodes a PRO polypeptide.
07/10/2003US20030129688 Heregulin variants
07/10/2003US20030129687 Keratinocyte growth factor-2
07/10/2003US20030129686 Novel nucleic acid and polypeptide molecules
07/10/2003US20030129685 12 human secreted proteins
07/10/2003US20030129663 Methods and compositions for modulating oxidized ldl transport
07/10/2003US20030129655 Nucleic acids encoding GTPase activating proteins
07/10/2003US20030129653 Treating aberrant cell growth, endocrine conditions, neurological conditions, and diseases or disorders related to the pituitary gland, colon, breast, lungs, and prostate
07/10/2003US20030129651 Expression and purification of ATM protein using vaccinia virus
07/10/2003US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129649 Conformational assays to detect binding to G protein-coupled receptors
07/10/2003US20030129644 Used in gene therapy
07/10/2003US20030129643 T1 receptor-like ligand I
07/10/2003US20030129639 GDU, a novel signalling protein
07/10/2003US20030129633 A helicase unwinds the DNA, a replicase synthesizes new DNA, and primase repeatedly synthesizes new primed starts on the lagging strand.
07/10/2003US20030129631 Three of three sets of RT-PCR-amplified transcripts from prostatic adenocarcinomas display multiple cancer-associated coding sequence changes; normal pp32 exerts antineoplastic effects through suppression of transformation.
07/10/2003US20030129625 Methods of using 5433, a human calcium channel family member
07/10/2003US20030129623 SR-BI regulatory sequences and therapeutic assays based on the same
07/10/2003US20030129619 Predicting the epidemic character of a Mycobacterium tuberculosis isolate and/or a selective advantage to be maintained in the host and/or the acquisition of multiple drug resistance (MDR) by the isolate
07/10/2003US20030129613 SECX polynucleotides and the membrane-associated or secreted polypeptides encoded by them
07/10/2003US20030129612 Dna modification proteins
07/10/2003US20030129610 New QTL's on chromosomes X, 2, 6 and 7 of pigs
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/10/2003US20030129603 Isolating a collection of polynucleotide sequences corresponding to accessible regions of cellular chromatin
07/10/2003US20030129601 Selecting the sequences encoding essential molecules as regulatory nucleotidic sequences and proteins for the survival or the virulence of mycobacterium species
07/10/2003US20030129599 Nucleotide sequence encoding a human hiwi gene; increasing retention of primitive CD34+ hematopoietic stem cells
07/10/2003US20030129597 Inhibiting EG-1 to inhibit angiogenesis and metastasis
07/10/2003US20030129595 Mutations associated with iron disorders
07/10/2003US20030129592 Identification and characterization of extracellular polypeptides having homology to EGF
07/10/2003US20030129588 Methods and reagents to detect and characterize norwalk and related viruses
07/10/2003US20030129587 Antigen/antibody specificity exchanger
07/10/2003US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase.
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129577 Especially serine proteinases comprising a first and second kunitz domain and can further comprise a C-terminal domain.
07/10/2003US20030129207 Obtaining a biological sample from the patient, contacting the sample with a binding agent that binds to a polypeptide, detecting amount of bounded polypeptide, comparing it to a predetermined cut-off value to determine presence of cancer
07/10/2003US20030129204 Vaccines against helminthic parasites
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129201 Methods of preventing and treating flavivirus infection in animals
07/10/2003US20030129199 Combined vaccine compositions
07/10/2003US20030129198 Methods to produce high levels of C. difficile toxins
07/10/2003US20030129197 Influenza vaccine
07/10/2003US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/10/2003US20030129195 Use of heat shock proteins
07/10/2003US20030129192 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/10/2003US20030129189 Angiogenesis inhibitors for treament of inflammation, cachexia, septic shock, cerebral malaria, arthritis, and graft-rejection
07/10/2003US20030129186 Compositions and methods for modulating blood-brain barrier transport
07/10/2003US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
07/10/2003US20030129176 Atherosclerosis-associated genes
07/10/2003US20030129174 Antihemophilic factor; insertion of culture product into blood; polypeptide
07/10/2003US20030129172 Animal growth regulator
07/10/2003US20030129171 Cloning mastitis gene; muscular disorders
07/10/2003US20030129164 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
07/10/2003US20030129162 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
07/10/2003US20030129159 Derivatisation of proteins
07/10/2003US20030129133 PACAP compositions and methods for tumor imaging and therapy
07/10/2003CA2506538A1 Bacterial superantigen vaccines
07/10/2003CA2472230A1 Diagnosis of helicobacter pylori with surface plasmon resonance
07/10/2003CA2472123A1 Proteins of non typable haemophilus influenzae
07/10/2003CA2471924A1 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
07/10/2003CA2471916A1 Modified bacterial surface layer proteins
07/10/2003CA2471385A1 Preventives/remedies for cancer
07/10/2003CA2471333A1 Modified tetracycline repressor protein compositions and methods of use
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471115A1 Peptidyl-trna hydrolase from pseudomonas aeruginosa
07/10/2003CA2471042A1 Expression vectors and promoters for heterologous gene expression
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2470313A1 Liquid composition of modified factor vii polypeptides
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003CA2462768A1 Self-assembling polymers, and materials fabricated therefrom
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325960A2 Negative strand RNA virus vector having autonomously replicating activity
07/09/2003EP1325959A1 Transformation system of fungus belonging to the genus monascus
07/09/2003EP1325957A2 Recombinant papilloma virus L1
1 ... 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 ... 2916